Whole-genome methylation sequencing reveals distinct impact of differential methylations on gene transcription in prostate cancer

American Journal of Pathology

Volumn 183, Issue 6, 2013, Pages 1960-1970

  Yu, Yan P ^a   Ding, Ying ^a   Chen, Rui ^a   Liao, Serena G ^a   Ren, Bao Guo ^a   Michalopoulos, Amantha ^a   Michalopoulos, George ^a   Nelson, Joel ^a   Tseng, George C ^a   Luo, Jian Hua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; RNA;

ADULT; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; CONSENSUS SEQUENCE; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER;

AGED; CPG ISLANDS; DNA METHYLATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 84888233019     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.08.018     Document Type: Article

References (44)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. J.H. Luo Gene expression alterations in human prostate cancer Drugs Today (Barc) 38 2002 713 719
3. J.H. Luo, Y.P. Yu, K. Cieply, F. Lin, P. Deflavia, R. Dhir, S. Finkelstein, G. Michalopoulos, and M. Becich Gene expression analysis of prostate cancers Mol Carcinog 33 2002 25 35
4. Y.P. Yu, D. Landsittel, L. Jing, J. Nelson, B. Ren, L. Liu, C. McDonald, R. Thomas, R. Dhir, S. Finkelstein, G. Michalopoulos, M. Becich, and J.H. Luo Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy J Clin Oncol 22 2004 2790 2799
5. Y.P. Yu, C. Song, G. Tseng, B.G. Ren, W. LaFramboise, G. Michalopoulos, J. Nelson, and J.H. Luo Genome abnormalities precede prostate cancer and predict clinical relapse Am J Pathol 180 2012 2240 2248
6. S.M. Dhanasekaran, T.R. Barrette, D. Ghosh, R. Shah, S. Varambally, K. Kurachi, K.J. Pienta, M.A. Rubin, and A.M. Chinnaiyan Delineation of prognostic biomarkers in prostate cancer Nature 412 2001 822 826
7. J.H. Kim, S.M. Dhanasekaran, R. Mehra, S.A. Tomlins, W. Gu, J. Yu, C. Kumar-Sinha, X. Cao, A. Dash, L. Wang, D. Ghosh, K. Shedden, J.E. Montie, M.A. Rubin, K.J. Pienta, R.B. Shah, and A.M. Chinnaiyan Integrative analysis of genomic aberrations associated with prostate cancer progression Cancer Res 67 2007 8229 8239
8. J.A. Magee, T. Araki, S. Patil, T. Ehrig, L. True, P.A. Humphrey, W.J. Catalona, M.A. Watson, and J. Milbrandt Expression profiling reveals hepsin overexpression in prostate cancer Cancer Res 61 2001 5692 5696
9. T. Ernst, M. Hergenhahn, M. Kenzelmann, C.D. Cohen, U. Ikinger, M. Kretzler, M. Hollstein, and H.J. Gröne Genexpressions-Analyse des Prostatacarcinomes [Gene expression profiling in prostatic cancer] German Verh Dtsch Ges Pathol 86 2002 165 175
10. G.V. Glinsky, A.B. Glinskii, A.J. Stephenson, R.M. Hoffman, and W.L. Gerald Gene expression profiling predicts clinical outcome of prostate cancer J Clin Invest 113 2004 913 923
11. M. Monk, and M. Grant Preferential X-chromosome inactivation, DNA methylation and imprinting Dev Suppl 1990 55 62
12. J.F. Hu, T.H. Vu, and A.R. Hoffman Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation J Biol Chem 271 1996 18253 18262
13. G. Yu, G.C. Tseng, Y.P. Yu, T. Gavel, J. Nelson, A. Wells, G. Michalopoulos, D. Kokkinakis, and J.H. Luo CSR1 suppresses tumor growth and metastasis of prostate cancer Am J Pathol 168 2006 597 607
14. Y.P. Yu, G. Yu, G. Tseng, K. Cieply, J. Nelson, M. Defrances, R. Zarnegar, G. Michalopoulos, and J.H. Luo Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis Cancer Res 67 2007 8043 8050
15. J.D. Brooks, M. Weinstein, X. Lin, Y. Sun, S.S. Pin, G.S. Bova, J.I. Epstein, W.B. Isaacs, and W.G. Nelson CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia Cancer Epidemiol Biomarkers Prev 7 1998 531 536
16. W. Lou, D. Krill, R. Dhir, M.J. Becich, J.T. Dong, H.F. Frierson Jr., W.B. Isaacs, J.T. Isaacs, and A.C. Gao Methylation of the CD44 metastasis suppressor gene in human prostate cancer Cancer Res 59 1999 2329 2331
17. M. Curradi, A. Izzo, G. Badaracco, and N. Landsberger Molecular mechanisms of gene silencing mediated by DNA methylation Mol Cell Biol 22 2002 3157 3173
18. L. Liu, J.H. Yoon, R. Dammann, and G.P. Pfeifer Frequent hypermethylation of the RASSF1A gene in prostate cancer Oncogene 21 2002 6835 6840
19. J.R. Graff, J.G. Herman, R.G. Lapidus, H. Chopra, R. Xu, D.F. Jarrard, W.B. Isaacs, P.M. Pitha, N.E. Davidson, and S.B. Baylin E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas Cancer Res 55 1995 5195 5199
20. J.G. Herman, A. Merlo, L. Mao, R.G. Lapidus, J.P. Issa, N.E. Davidson, D. Sidransky, and S.B. Baylin Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers Cancer Res 55 1995 4525 4530
21. H. Kito, H. Suzuki, T. Ichikawa, N. Sekita, N. Kamiya, K. Akakura, T. Igarashi, T. Nakayama, M. Watanabe, K. Harigaya, and H. Ito Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer Prostate 49 2001 110 115
22. D.K. Vanaja, J.C. Cheville, S.J. Iturria, and C.Y. Young Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression Cancer Res 63 2003 3877 3882
23. K. Woodson, R. Hayes, L. Wideroff, L. Villaruz, and J. Tangrea Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US blacks and whites Prostate 55 2003 199 205
24. K. Yoshiura, Y. Kanai, A. Ochiai, Y. Shimoyama, T. Sugimura, and S. Hirohashi Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas Proc Natl Acad Sci USA 92 1995 7416 7419
25. P.J. Bastian, S. Yegnasubramanian, G.S. Palapattu, C.G. Rogers, X. Lin, A.M. De Marzo, and W.G. Nelson Molecular biomarker in prostate cancer: the role of CpG island hypermethylation Eur Urol 46 2004 698 708
26. M. Nakayama, M.L. Gonzalgo, S. Yegnasubramanian, X. Lin, A.M. De Marzo, and W.G. Nelson GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer J Cell Biochem 91 2004 540 552
27. G.H. Kang, S. Lee, H.J. Lee, and K.S. Hwang Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia J Pathol 202 2004 233 240
28. F. Krueger, and S.R. Andrews Bismark: a flexible aligner and methylation caller for bisulfite-seq applications Bioinformatics 27 2011 1571 1572
29. C. Trapnell, A. Roberts, L. Goff, G. Pertea, D. Kim, D.R. Kelley, H. Pimentel, S.L. Salzberg, J.L. Rinn, and L. Pachter Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks Nat Protoc 7 2012 562 578
30. C. Trapnell, L. Pachter, and S.L. Salzberg TopHat: discovering splice junctions with RNA-seq Bioinformatics 25 2009 1105 1111
31. C. Trapnell, B.A. Williams, G. Pertea, A. Mortazavi, G. Kwan, M.J. van Baren, S.L. Salzberg, B.J. Wold, and L. Pachter Transcript assembly and quantification by RNA-seq reveals unannotated transcripts and isoform switching during cell differentiation Nat Biotechnol 28 2010 511 515
32. A. Akalin, M. Kormaksson, S. Li, F.E. Garrett-Bakelman, M.E. Figueroa, A. Melnick, and C.E. Mason methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles Genome Biol 13 2012 R87
33. P.A. Jones, and D. Takai The role of DNA methylation in mammalian epigenetics Science 293 2001 1068 1070
34. D. Takai, and P.A. Jones The CpG island searcher: a new WWW resource. In Silico Biol 3 2003 235 240
35. T.L. Bailey, and C. Elkan Fitting a mixture model by expectation maximization to discover motifs in biopolymers Proc Int Conf Intell Syst Mol Biol 2 1994 28 36
36. S. Gupta, J. Stamatoyannopolous, T. Bailey, and W. Noble Quantifying similarity between motifs Genome Biol 8 2007 R24
37. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci USA 102 2005 15545 15550
38. H. Wu, B. Caffo, H.A. Jaffee, R.A. Irizarry, and A.P. Feinberg Redefining CpG islands using hidden Markov models Biostatistics 11 2010 499 514
39. Y. Kobayashi, D.M. Absher, Z.G. Gulzar, S.R. Young, J.K. McKenney, D.M. Peehl, J.D. Brooks, R.M. Myers, and G. Sherlock DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer Genome Res 21 2011 1017 1027
40. J.H. Kim, S.M. Dhanasekaran, J.R. Prensner, X. Cao, D. Robinson, S. Kalyana-Sundaram, C. Huang, S. Shankar, X. Jing, M. Iyer, M. Hu, L. Sam, C. Grasso, C.A. Maher, N. Palanisamy, R. Mehra, H.D. Kominsky, J. Siddiqui, J. Yu, Z.S. Qin, and A.M. Chinnaiyan Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer Genome Res 21 2011 1028 1041
41. Y.P. Yu, S. Paranjpe, J. Nelson, S. Finkelstein, B. Ren, D. Kokkinakis, G. Michalopoulos, and J.H. Luo High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array Carcinogenesis 26 2005 471 479
42. J.H. Luo, Y. Ding, R. Chen, G. Michalopoulos, J. Nelson, G. Tseng, and Y.P. Yu Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer Am J Pathol 182 2013 2028 2036
43. M. Truong, B. Yang, A. Livermore, J. Wagner, P. Weeratunga, W. Huang, R. Dhir, J. Nelson, D.W. Lin, and D.F. Jarrard Using the epigenetic field defect to detect prostate cancer in biopsy negative patients J Urol 189 2013 2335 2341
44. B. Yang, S. Bhusari, J. Kueck, P. Weeratunga, J. Wagner, G. Leverson, W. Huang, and D.F. Jarrard Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer Neoplasia 15 2013 399 408